|
Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
|
ARK Genomic Revolution UCITS ETF
IE000O5M6XO1
USD / Acc. / Retail
|
12.04.2024
2,4 Jahre
|
81,29 |
+63,93% |
+93,00% |
N/A |
N/A |
|
Aescap Life Sciences
NL0012343958
EUR / Acc. / Retail
|
29.03.2016
10,5 Jahre
|
137,38 |
+7,62% |
+53,36% |
+66,76% |
+22,11% |
|
Allianz Biotechnologie
DE0008481862
EUR / Dist. / Retail
|
09.01.1998
28,7 Jahre
|
295,06 |
+15,17% |
+38,96% |
+40,31% |
+19,04% |
|
ERSTE STOCK BIOTEC
AT0000746755
EUR / Acc. / Retail
|
17.04.2000
26,4 Jahre
|
298,97 |
+14,35% |
+40,16% |
+49,49% |
+35,17% |
|
JPMorgan Funds - Thematics - Genetic Therapies Fund
LU2050612402
USD / Acc. / Retail
|
24.10.2019
6,9 Jahre
|
354,06 |
+21,09% |
+47,92% |
+25,24% |
-22,34% |
|
DWS ESG Biotech
DE0009769976
EUR / Acc. / Retail
|
16.08.1999
27,1 Jahre
|
385,83 |
+11,36% |
+40,65% |
+43,74% |
+28,75% |
|
Invesco NASDAQ Biotech UCITS ETF
IE00BQ70R696
USD / Acc. / Retail
|
06.11.2014
11,9 Jahre
|
429,77 |
+26,39% |
+53,76% |
+63,51% |
+38,04% |
|
UBS (Lux) Equity Fund - Biotech (USD)
LU0069152568
USD / Acc. / Retail
|
15.10.1996
29,9 Jahre
|
469,89 |
+25,60% |
+54,01% |
+52,58% |
+29,70% |
|
iShares Nasdaq US Biotechnology UCITS ETF
IE00BYXG2H39
USD / Acc. / Retail
|
19.10.2017
8,9 Jahre
|
1.097,26 |
+26,26% |
+53,52% |
+63,31% |
+37,82% |
|
Candriam Equities L Biotechnology
LU0108459040
USD / Acc. / Retail
|
06.04.2000
26,5 Jahre
|
1.813,67 |
+23,45% |
+57,33% |
+75,28% |
+74,75% |